MediBeacon focus is fluorescent tracer agents and their transdermal detection. The goal is point of care organ function measurement. There are over 300 peer-reviewed publications and conference abstracts in which preclinical Transdermal GFR was used. These include kidney therapeutics and nephrotoxicity studies as well as work to fundamentally understand kidney function.